Topic

Vitrakvi (larotrectinib)

A collection of 35 issues

Renewing Vitrakvi (Larotrectinib) Approval with Humana in Washington: Timeline, Documentation & Appeals Guide

Answer Box: Renewing Vitrakvi Coverage with Humana in Washington Vitrakvi (larotrectinib) requires prior authorization renewal with Humana every 3-6 months. Start your renewal 30-45 days before expiration. Submit: updated clinical notes showing continued benefit, recent imaging demonstrating response/stable disease, current liver function tests, and NTRK fusion documentation. If denied,

Getting Vitrakvi (Larotrectinib) Covered by Cigna in New Jersey: Prior Authorization Guide and Appeal Scripts

Answer Box: Getting Vitrakvi (Larotrectinib) Covered by Cigna in New Jersey Eligibility: Cigna requires prior authorization for Vitrakvi (larotrectinib) with documented NTRK gene fusion, unresectable/metastatic solid tumors, and oncologist prescribing. Fastest path: Submit PA request via CoverMyMeds portal with NTRK fusion test results, prior therapy documentation, and medical necessity

How to Get Vitrakvi (Larotrectinib) Covered by Aetna CVS Health in Texas: Complete Coverage and Appeal Guide

Answer Box: Getting Vitrakvi Covered by Aetna CVS Health in Texas Vitrakvi (larotrectinib) requires prior authorization with Aetna CVS Health in Texas and documentation of a positive NTRK gene fusion test. The fastest path to approval: (1) Ensure your oncologist has your NTRK fusion test results ready, (2) Submit the

How to Get Vitrakvi (Larotrectinib) Covered by UnitedHealthcare in Florida: 2025 PA Requirements and Appeal Guide

Quick Answer: Getting Vitrakvi Covered by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Vitrakvi (larotrectinib) in Florida. To get approved: (1) Submit a PA request through OptumRx with confirmed NTRK gene fusion testing results, (2) document that your solid tumor is metastatic/unresectable with no satisfactory alternatives, and (3)

How to Get Vitrakvi (Larotrectinib) Covered by UnitedHealthcare in Texas: Complete Forms, Appeals & Contact Guide

Answer Box: Getting Vitrakvi Covered in Texas UnitedHealthcare requires prior authorization for Vitrakvi (larotrectinib) in Texas. For patients under 19, approval requires only age verification. Adults need documented NTRK gene fusion, metastatic/unresectable tumor, and no satisfactory alternatives. Submit the UnitedHealthcare PA form with molecular testing results through the provider